Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To determine if co-administration of subcutaneous (SQ)Insulin glargine in combination with intravenous (IV) insulin decreases the time to resolution of ketoacidosis and requirement for ICU admission compared to IV insulin with delayed administration of SQ glargine for the treatment of diabetic ketoacidosis (DKA).
Epistemonikos ID: 12846202a5d23cca6c17dfe703a993ba5d38d3b9
First added on: May 11, 2024